ARKO Corp. (ARKO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 1, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ARKO SEC filings page.
ARKO Corp. (ARKO) reported $7.9B in revenue over the twelve months to Jun 30, 2026, down 2.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Thin-margin cash conversion supports operations, while rising leverage increases dependence on balance-sheet financing.
In FY2025, operating cash flow of$192.6M was over eight times net income of$22.7M , so reported profit understates cash produced. But depreciation and amortization of$134.5M nearly matched capital expenditures of$127.3M , indicating that much of the cash advantage reflects non-cash expense reversal and working-capital movement rather than earnings strength.
Operating margin recovered from
Leverage rose from 3.0x in FY2023 to 3.3x in FY2025, making debt a larger claim on a shrinking equity base. A FY2025 current ratio of 1.7x indicates short-term assets exceeded short-term obligations, but does not offset the longer-term leverage trend.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of ARKO Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ARKO Corp. has an operating margin of 1.3%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 49/100, indicating healthy but not exceptional operating efficiency. This is up from 1.1% the prior year.
ARKO Corp.'s revenue declined 12.5% year-over-year, from $8.7B to $7.6B. This contraction results in a growth score of 10/100.
ARKO Corp. has elevated debt relative to equity (D/E of 3.28), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 27/100, reflecting increased financial risk.
ARKO Corp.'s current ratio of 1.66 indicates adequate short-term liquidity, earning a score of 48/100. The company can meet its near-term obligations, though with limited headroom.
ARKO Corp.'s free cash flow margin of 0.9% results in a low score of 28/100. Capital expenditures of $127.3M absorb a large share of operating cash flow.
ARKO Corp.'s ROE of 8.5% shows moderate profitability relative to equity, earning a score of 51/100. This is up from 7.5% the prior year.
ARKO Corp. scores 2.48, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
ARKO Corp. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, ARKO Corp. generates $8.47 in operating cash flow ($192.6M OCF vs $22.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
ARKO Corp. earns $1.10 in operating income for every $1 of interest expense ($102.3M vs $92.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
ARKO Corp. generated $2.3B in revenue in Q2 2026. This represents an increase of 17.4% from the same quarter a year earlier. Against the prior quarter it is up 32.4%.
ARKO Corp.'s EBITDA was $62.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 30.7% from the same quarter a year earlier. Against the prior quarter it is up 47.5%.
ARKO Corp. reported $6.1M in net income in Q2 2026. This represents a decrease of 69.6% from the same quarter a year earlier. Against the prior quarter it is up 192.1%.
ARKO Corp. earned $0.04 per diluted share (EPS) in Q2 2026. This represents a decrease of 75.0% from the same quarter a year earlier.
Cash & Balance Sheet
ARKO Corp. generated $8.9M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 9.5% from the same quarter a year earlier. Against the prior quarter it is up 176.7%.
ARKO Corp. held $245.6M in cash against $658.5M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
ARKO Corp.'s operating margin was 1.3% in Q2 2026, reflecting core business profitability. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.
ARKO Corp.'s net profit margin was 0.3% in Q2 2026, showing the share of revenue converted to profit. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
ARKO Corp.'s ROE was 1.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 6.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.2 percentage points.
Not reported for Q2 2026.
Capital Allocation
ARKO Corp. spent $212K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 97.7% from the same quarter a year earlier. Against the prior quarter it is down 95.1%.
ARKO Corp. invested $33.3M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 26.6% from the same quarter a year earlier. Against the prior quarter it is up 10.0%.
Not reported for Q2 2026.
ARKO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B+17.4% | $1.8B-3.1% | $1.8B-9.9% | $2.0B-11.3% | $2.0B-16.3% | $1.8B-11.7% | $2.0B-10.8% | $2.3B-13.1% |
| SG&A Expenses | $43.7M+7.3% | $40.0M-3.9% | $43.3M+9.1% | $40.0M+3.7% | $40.7M-4.0% | $41.6M-1.3% | $39.7M+4.2% | $38.6M-12.4% |
| Operating Income | $30.4M-46.4% | $10.0M+185.3% | $21.5M+49.2% | $35.9M-13.6% | $56.7M+32.0% | -$11.8M-141.8% | $14.4M-43.2% | $41.6M-5.7% |
| EBITDA | $62.5M-30.7% | $42.4M+83.4% | $54.5M+12.6% | $68.9M-7.8% | $90.3M+18.0% | $23.1M-13.9% | $48.4M-16.5% | $74.7M-4.0% |
| Interest Expense | $19.8M-14.8% | $20.7M-11.2% | $22.8M+4.8% | $23.5M-12.2% | $23.2M-6.2% | $23.3M-4.7% | $21.8M-9.9% | $26.8M+11.7% |
| Income Tax | $6.9M-59.4% | -$2.5M+80.7% | -$204K+93.2% | $2.4M-71.5% | $17.1M+126.6% | -$12.9M-92.7% | -$3.0M-327.4% | $8.3M+3.8% |
| Net Income | $6.1M-69.6% | -$6.6M+47.6% | $1.9M+180.9% | $13.5M+39.1% | $20.1M+42.9% | -$12.7M-2033.3% | -$2.3M-313.2% | $9.7M-54.9% |
| EPS (Basic) | $0.04-75.0% | -$0.07+41.7% | $0.00+100.0% | $0.11+57.1% | $0.16+45.5% | -$0.12-500.0% | -$0.03 | $0.07-58.8% |
| EPS (Diluted) | $0.04-75.0% | -$0.07+41.7% | $0.01 | $0.10+42.9% | $0.16+45.5% | -$0.12 | -$0.03 | $0.07-58.8% |
| Diluted Shares (Avg) | 116M+0.4% | 111M-3.9% | N/A | 115M-2.3% | 115M-1.3% | 116M | N/A | 118M-2.0% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
ARKO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6B-1.4% | $3.6B-0.7% | $3.5B-2.4% | $3.6B-2.7% | $3.6B-2.5% | $3.6B-0.5% | $3.6B-0.8% | $3.7B-0.8% |
| Current Assets | $744.5M+0.1% | $769.7M+7.0% | $717.7M-0.6% | $753.2M-3.4% | $743.5M-3.4% | $719.2M-2.2% | $722.2M-3.6% | $779.9M-0.8% |
| Cash & Equivalents | $245.6M-16.4% | $272.1M+2.5% | $305.0M+16.5% | $306.9M+5.2% | $293.7M+26.8% | $265.4M+43.9% | $261.8M+20.0% | $291.7M+42.8% |
| Short-Term Investments | $8.2M+36.4% | $7.2M+27.3% | $6.5M+21.3% | $6.3M+22.7% | $6.0M+23.2% | $5.7M+23.5% | $5.3M+36.9% | $5.1M+52.1% |
| Inventory | $208.5M+0.6% | $206.3M-6.5% | $190.7M-17.5% | $202.3M-14.5% | $207.2M-17.5% | $220.7M-11.9% | $231.2M-7.7% | $236.5M-11.1% |
| Accounts Receivable | N/A | N/A | $87.3M-8.9% | N/A | N/A | N/A | $95.8M-28.9% | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $300.0M0.0% | $300.0M0.0% | $300.0M0.0% | $300.0M0.0% | $300.0M0.0% | $300.0M+2.7% | $300.0M+2.7% | $300.0M+7.8% |
| Total Liabilities | $3.0B-7.9% | $3.0B-7.0% | $3.2B-2.3% | $3.2B-2.9% | $3.2B-2.5% | $3.2B-0.4% | $3.2B-0.9% | $3.3B-0.7% |
| Current Liabilities | $464.2M-3.5% | $475.1M+2.6% | $433.0M-2.8% | $465.6M-2.9% | $481.0M-1.5% | $462.9M-3.5% | $445.5M-8.4% | $479.3M-9.2% |
| Non-Current Liabilities | $2.5B-8.7% | $2.5B-8.6% | $2.7B-2.3% | $2.7B-2.9% | $2.8B-2.7% | $2.8B+0.2% | $2.8B+0.4% | $2.8B+0.9% |
| Long-Term Debt | $658.5M-24.9% | $691.0M-20.2% | $875.5M+0.9% | $874.6M+0.6% | $876.5M+0.6% | $866.1M-0.2% | $868.1M+4.8% | $869.3M+7.0% |
| Total Equity | $402.1M+51.8% | $395.4M+54.9% | $267.2M-3.5% | $273.1M-2.5% | $264.8M-3.0% | $255.2M-2.3% | $276.9M+0.3% | $280.0M-2.4% |
| Retained Earnings | $90.4M-4.6% | $89.1M+12.0% | $100.5M+3.5% | $103.5M-0.9% | $94.8M-4.8% | $79.6M-12.0% | $97.2M+1.1% | $104.4M+4.4% |
ARKO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $42.2M-23.5% | $18.7M-57.0% | $44.6M+96.1% | $49.4M-54.7% | $55.2M-28.5% | $43.4M+240.3% | $22.7M-60.3% | $109.2M+232.6% |
| Depreciation & Amortization | $32.2M-4.3% | $32.4M-7.2% | $33.0M-2.9% | $32.9M-0.6% | $33.6M+0.1% | $34.9M+10.0% | $34.0M+4.1% | $33.1M-1.7% |
| Stock-Based Compensation | N/A | $4.0M+19.3% | N/A | N/A | N/A | $3.3M+0.2% | N/A | N/A |
| Capital Expenditures | $33.3M-26.6% | $30.3M+10.5% | $29.6M-18.0% | $24.9M-14.9% | $45.3M+135.2% | $27.4M-6.3% | $36.1M+1.6% | $29.3M+14.5% |
| Free Cash Flow | $8.9M-9.5% | -$11.6M-172.5% | $14.9M+211.4% | $24.5M-69.3% | $9.8M-83.0% | $16.0M+197.2% | -$13.4M-161.7% | $79.9M+1001.0% |
| Investing Cash Flow | -$28.3M+35.0% | -$29.4M-9.1% | -$26.1M+23.2% | -$23.3M+17.7% | -$43.5M-77.9% | -$26.9M+4.5% | -$33.9M-1.6% | -$28.3M-0.2% |
| Financing Cash Flow | -$42.4M-378.0% | -$23.9M-23.4% | -$20.5M-33.0% | -$16.9M-30.9% | $15.3M+306.1% | -$19.4M+4.5% | -$15.4M-408.1% | -$12.9M+33.4% |
| Dividends Paid | $3.3M-3.2% | $3.4M-2.9% | $3.3M-4.6% | $3.4M-2.4% | $3.4M-1.8% | $3.5M-2.7% | $3.5M-1.9% | $3.5M-2.4% |
| Share Buybacks | $212K-97.7% | $4.3M-41.9% | $7.2M | $4.2M | $9.2M+13442.6% | $7.4M-76.9% | $0-100.0% | $0-100.0% |
ARKO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3%-1.6pp | 0.6%+1.2pp | 1.2%+0.5pp | 1.8%0.0pp | 2.8%+1.0pp | -0.6%-0.4pp | 0.7%-0.4pp | 1.8%+0.1pp |
| Net Margin | 0.3%-0.8pp | -0.4%+0.3pp | 0.1%+0.2pp | 0.7%+0.3pp | 1.0%+0.4pp | -0.7%-0.7pp | -0.1%-0.2pp | 0.4%-0.4pp |
| Return on Equity | 1.5%-6.1pp | -1.7%+3.3pp | 0.7%+1.5pp | 4.9%+1.5pp | 7.6%+2.4pp | -5.0%-4.7pp | -0.8%-1.2pp | 3.5%-4.0pp |
| Return on Assets | 0.2%-0.4pp | -0.2%+0.2pp | 0.1%+0.1pp | 0.4%+0.1pp | 0.6%+0.2pp | -0.4%-0.3pp | -0.1%-0.1pp | 0.3%-0.3pp |
| Current Ratio | 1.60+0.1x | 1.62+0.1x | 1.660.0x | 1.620.0x | 1.550.0x | 1.550.0x | 1.62+0.1x | 1.63+0.1x |
| Debt-to-Equity | 1.64-1.7x | 1.75-1.6x | 3.28+0.1x | 3.20+0.1x | 3.31+0.1x | 3.39+0.1x | 3.14+0.1x | 3.10+0.3x |
| Asset Turnover | 0.66+0.1x | 0.500.0x | 0.510.0x | 0.56-0.1x | 0.55-0.1x | 0.51-0.1x | 0.55-0.1x | 0.62-0.1x |
| FCF Margin | 0.4%-0.1pp | -0.7%-1.5pp | 0.8%+1.5pp | 1.2%-2.3pp | 0.5%-1.9pp | 0.9%+1.7pp | -0.7%-1.6pp | 3.5%+3.2pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ARKO Corp. ARKO | FY2025 | $7.6B | $22.7M | 0.3% | $461.1M | 36/100 |
| The ODP Corporation ODP | FY2024 | $7.0B | -$3.0M | 0.0% | $843.3M | 41/100 |
| MarineMax, Inc. HZO | FY2025 | $2.3B | -$31.6M | -1.4% | $1.2B | 33/100 |
| Betterware de Mexico, S.A.P.I. de C.V. BWMX | FY2022 | N/A | $872.6M | N/A | $618.6M | — |
| Petco Health and Wellness Company, Inc. WOOF | FY2025 | $6.0B | $9.1M | 0.1% | $650.2M | 21/100 |
| 1-800-FLOWERS.COM Inc FLWS | FY2026 | $1.5B | -$134.8M | -9.0% | $160.5M | 23/100 |
Where ARKO Corp. Ranks
Frequently Asked Questions
What is ARKO Corp.'s annual revenue?
ARKO Corp. (ARKO) reported $7.6B in total revenue for fiscal year 2025. This represents a -12.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ARKO Corp.'s revenue growing?
ARKO Corp. (ARKO) revenue declined by 12.5% year-over-year, from $8.7B to $7.6B in fiscal year 2025.
Is ARKO Corp. profitable?
Yes, ARKO Corp. (ARKO) reported a net income of $22.7M in fiscal year 2025, with a net profit margin of 0.3%.
What is ARKO Corp.'s EBITDA?
ARKO Corp. (ARKO) had EBITDA of $236.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does ARKO Corp. have?
As of fiscal year 2025, ARKO Corp. (ARKO) had $305.0M in cash and equivalents against $875.5M in long-term debt.
What is ARKO Corp.'s operating margin?
ARKO Corp. (ARKO) had an operating margin of 1.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is ARKO Corp.'s net profit margin?
ARKO Corp. (ARKO) had a net profit margin of 0.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ARKO Corp.'s return on equity (ROE)?
ARKO Corp. (ARKO) has a return on equity of 8.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ARKO Corp.'s free cash flow?
ARKO Corp. (ARKO) generated $65.3M in free cash flow during fiscal year 2025. This represents a -39.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is ARKO Corp.'s operating cash flow?
ARKO Corp. (ARKO) generated $192.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ARKO Corp.'s total assets?
ARKO Corp. (ARKO) had $3.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are ARKO Corp.'s capital expenditures?
ARKO Corp. (ARKO) invested $127.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is ARKO Corp.'s current ratio?
ARKO Corp. (ARKO) had a current ratio of 1.66 as of fiscal year 2025, which is generally considered healthy.
What is ARKO Corp.'s debt-to-equity ratio?
ARKO Corp. (ARKO) had a debt-to-equity ratio of 3.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ARKO Corp.'s return on assets (ROA)?
ARKO Corp. (ARKO) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ARKO Corp.'s P/E ratio?
ARKO Corp. (ARKO) trades at 31.2x earnings, its market capitalization divided by net income of $14.8M net income, trailing 12 months to June 30, 2026. The market capitalization is $461.1M as of Oct 1, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ARKO Corp.'s price-to-sales ratio?
ARKO Corp. (ARKO) trades at 0.1x sales, its market capitalization divided by revenue of $7.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $461.1M as of Oct 1, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is ARKO Corp.'s Altman Z-Score?
ARKO Corp. (ARKO) has an Altman Z-Score of 2.48, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is ARKO Corp.'s Piotroski F-Score?
ARKO Corp. (ARKO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ARKO Corp.'s earnings high quality?
ARKO Corp. (ARKO) has an earnings quality ratio of 8.47x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can ARKO Corp. cover its interest payments?
ARKO Corp. (ARKO) has an interest coverage ratio of 1.10x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is ARKO Corp.?
ARKO Corp. (ARKO) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.